Metabolic Radiomics for Pretreatment (18)F-FDG PET/CT to Characterize Locally Advanced Breast Cancer: Histopathologic Characteristics, Response to Neoadjuvant Chemotherapy, and Prognosis

Radiomics has been spotlighted as imaging biomarker for estimation of intratumoral heterogeneity (ITH) which is regarded as the main reason for resistance to tumor treatment. Although a number of studies has shown clinical evidences that separate measurement of metabolic ITH by texture features (TFs...

Descripción completa

Detalles Bibliográficos
Autores principales: Ha, Seunggyun, Park, Sohyun, Bang, Ji-In, Kim, Eun-Kyu, Lee, Ho-Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5431555/
https://www.ncbi.nlm.nih.gov/pubmed/28484211
http://dx.doi.org/10.1038/s41598-017-01524-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5431555/
https://www.ncbi.nlm.nih.gov/pubmed/28484211
http://dx.doi.org/10.1038/s41598-017-01524-7

Ejemplares similares